What We're Reading: Page
Industry reads hand-picked by our editors
Jul 07, 2026
Jul 06, 2026
-
The Wall Street Journal
Drugmaker Ipsen Sees More Deals Coming to Continue Buying Spree
-
Houston Business Journal
Houston biotech, pharma deals rise after VC funding ups and downs
-
Stat
I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
Jul 02, 2026
Jul 01, 2026
-
Stat
AI company Anthropic announces it will begin developing drugs of its own
-
Reuters
US House committee opens investigation into Merck, AbbVie China drug trials
-
Boston Business Journal
Massachusetts biotech layoffs drop to lowest level in over two years
-
The Wall Street Journal
The Latest Senior-Citizen Special Is Here: Cheap Weight-Loss Drugs
Jun 30, 2026
-
The Wall Street Journal
Biotech Investor Pumps the Brakes on AI Drug Discovery
-
Reuters
Medical journal retracts paper on Amgen’s Tavneos drug trial after FDA findings
-
South China Morning Post
Hong Kong draws royalties giant as mainland China biotech licensing heats up
Jun 29, 2026
Jun 26, 2026
-
The Wall Street Journal
InSilico Is on a Mission: Be No. 1 in China, Create ‘God Drug’ With AI
-
Quanta Magazine
Why the Human Genome’s Tangled Physicality May Confound AI
-
The Financial Times
Brussels launches antitrust probe into French drugmaker Sanofi
-
Stat
Jails are the frontline in fielding dangerous new type of drug withdrawal
Previous
